BUZZ-Intellipharmaceutics International Inc: Teva to market drug in US
** Canadian drugmaker's U.S.-listed shares up 7.8 pct at $2.20
** Toronto-listed shares up 8.5 percent at C$2.80
** Israel-based Teva Pharmaceutical will exclusively market Intellipharmaceutics' generic oral drugs in the United States
** Intellipharmaceutics' Toronto-listed stock declined about 33 pct over last 12 months
© Thomson Reuters 2017 All rights reserved.